KR102843808B1 - The cosmetic composition containing Vicia faba-derived PDRN - Google Patents
The cosmetic composition containing Vicia faba-derived PDRNInfo
- Publication number
- KR102843808B1 KR102843808B1 KR1020250066915A KR20250066915A KR102843808B1 KR 102843808 B1 KR102843808 B1 KR 102843808B1 KR 1020250066915 A KR1020250066915 A KR 1020250066915A KR 20250066915 A KR20250066915 A KR 20250066915A KR 102843808 B1 KR102843808 B1 KR 102843808B1
- Authority
- KR
- South Korea
- Prior art keywords
- pdrn
- derived
- cosmetic composition
- efficacy
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 파바빈(Vicia faba) 유래 PDRN을 유효성분으로 포함하는 화장료 조성물에 관한 것으로, 본 발명에 따른 파바빈 유래 PDRN은 우수한 색소침착 방지, 미백, 주름 개선, 피부탄력 개선, 항염의 효과를 가지므로 화장료 조성물로서 유용하게 사용될 수 있다.The present invention relates to a cosmetic composition comprising PDRN derived from faba bean ( Vicia faba ) as an active ingredient. The PDRN derived from faba bean according to the present invention has excellent effects of preventing pigmentation, whitening, improving wrinkles, improving skin elasticity, and anti-inflammation, and thus can be usefully used as a cosmetic composition.
Description
본 발명은 파바빈(Vicia faba) 유래 PDRN을 유효성분으로 포함하는 화장료 조성물에 관한 것으로, 본 발명에 따른 파바빈 유래 PDRN은 우수한 색소침착 방지, 미백, 주름 개선, 피부탄력 개선, 항염의 효과를 가지므로 화장료 조성물로서 유용하게 사용될 수 있다.The present invention relates to a cosmetic composition comprising PDRN derived from faba bean ( Vicia faba ) as an active ingredient. The PDRN derived from faba bean according to the present invention has excellent effects of preventing pigmentation, whitening, improving wrinkles, improving skin elasticity, and anti-inflammation, and thus can be usefully used as a cosmetic composition.
PDRN(Polydeoxyribonucleotide)은 손상된 조직과 세포의 자가 재생을 촉진하는 조직 재생 활성 물질로, DNA로부터 제조된 분자량 50~1500 kDa 범위의 중합체이다. PDRN은 조직 복구, 항허혈, 항염증 등의 다양한 효능을 지니고 있어, 재생 의학 및 당뇨병성 족부 궤양 치료에 적용 가능성이 제시되고 있다.PDRN (Polydeoxyribonucleotide) is a tissue regeneration-activating substance that promotes the self-regeneration of damaged tissues and cells. It is a polymer manufactured from DNA with a molecular weight ranging from 50 to 1,500 kDa. PDRN possesses diverse efficacies, including tissue repair, anti-ischemia, and anti-inflammation, suggesting its potential applications in regenerative medicine and the treatment of diabetic foot ulcers.
일반적으로 PDRN은 연어와 같은 대형 어류의 정액 및 정소에서 DNA를 추출한 후 대량 정제된다. 하지만 어류의 대량 폐사 위험, 감염 가능성, 그리고 추출 시기의 제한성 등 몇 가지 문제가 존재한다. 이에 그 대안으로 식물성 PDRN의 확보와 활용에 관심이 집중되고 있다.PDRN is typically extracted from the semen and testes of large fish, such as salmon, and then purified in large quantities. However, several issues arise, including the risk of mass fish mortality, the potential for infection, and limited extraction times. Consequently, interest is focused on securing and utilizing plant-based PDRN as an alternative.
본 발명과 관계되는 식물성 PDRN은 동물성 PDRN 대신 식물에서 추출한 폴리뉴클레오티드 물질을 의미한다. 기존의 PDRN은 주로 연어와 같은 대형 어류의 정액 또는 정소에서 DNA를 추출하여 제조되나, 식물 PDRN은 식물에서 DNA를 추출하여 이를 기반으로 제조된다. 식물 PDRN의 경우 대량 재배 및 연중 수확이 가능하여, 어류 기반 PDRN이 가진 시기적 제한성, 대량 폐사 및 감염 가능성 등의 문제를 해결할 수 있다는 점에서 효과적 대안으로 제시될 수 있다.Plant-derived PDRN, as used herein, refers to a polynucleotide material extracted from plants instead of animal-derived PDRN. Conventional PDRN is primarily manufactured by extracting DNA from the semen or testes of large fish, such as salmon. Plant-derived PDRN is manufactured based on plant-derived DNA. Plant-derived PDRN can be mass-produced and harvested year-round, making it an effective alternative to fish-derived PDRN, as it addresses the limitations of seasonality, mass mortality, and the potential for infection.
특히, 식물 유래 PDRN은 동물성 조직에서 유래한 바이러스가 혼입될 위험이 없으므로, 인수공통 감염 등의 바이러스 감염 위험성을 최소화할 수 있다. 이러한 이유로 식물 PDRN은 조직 재생, 항염증, 항허혈 등의 효능을 통해 재생 의학 및 관련 의료 분야에서 대체 물질로서의 활용 가능성이 주목받고 있다.In particular, plant-derived PDRN minimizes the risk of viral infections, including zoonotic infections, because it is free from the risk of contamination by viruses derived from animal tissues. For these reasons, plant PDRN is attracting attention as an alternative agent in regenerative medicine and related medical fields, due to its tissue regeneration, anti-inflammatory, and anti-ischemic properties.
최근 뷰티 업계에서도 피부 재생 효과가 있는 PDRN 성분이 주목받고 있으며, 이를 활용한 신제품이 잇따라 출시되고 있다. PDRN은 섬유아세포의 재생과 대사 활동을 촉진해 피부 상태를 개선하는 성분으로, 특히 스킨부스터 제품에서 인기를 끌고 있다. 스킨부스터는 피부에 유효 성분을 주입해 피부 재생을 돕는 제품으로 관련 시장 규모는 2조 원을 넘을 것으로 예측된다. 대표적 기업으로 아모레퍼시픽과 에이피알이 PDRN을 포함한 제품을 출시 중이다. 아모레퍼시픽의 이니스프리는 '레티놀 그린티 PDRN 스킨부스터 앰플'을, 에이피 뷰티는 '듀얼 리페어 리프트 크림'을 선보였다. 에이피알은 PDRN 함유 앰플과 크림을 자체 생산할 계획이다. PDRN 제품에 대한 수요가 증가하면서 뷰티 업계는 스킨부스터 시장의 성장을 기대하고 있다.The beauty industry has recently been garnering attention for its skin regeneration properties, with new products utilizing PDRN being released one after another. PDRN, an ingredient that improves skin condition by promoting fibroblast regeneration and metabolic activity, is particularly popular in skin booster products. Skin boosters, which inject effective ingredients into the skin to promote skin regeneration, are expected to have a market size exceeding 2 trillion won. Leading companies such as Amorepacific and APR are currently releasing products containing PDRN. Amorepacific's Innisfree launched the "Retinol Green Tea PDRN Skin Booster Ampoule," while AP Beauty launched the "Dual Repair Lift Cream." APR plans to produce its own PDRN-containing ampoules and creams. With increasing demand for PDRN products, the beauty industry anticipates the growth of the skin booster market.
본 발명의 발명자가 주목한 파바빈(Vicia faba)은 누에콩, 작두콩, 마마콩 등 다양한 이름으로 불린다. 단백질과 식이섬유가 풍부하게 함유되어 있고 각종 비타민과 무기질을 고루 가진 영양가 높은 식품이며, 염증 완화에 도움을 주고 혈중 콜레스테롤을 감소시키는 효능이 있다.Fava beans ( Vicia faba ), which the inventor of the present invention focused on, are known by various names, including broad beans, sword beans, and mama beans. Rich in protein and dietary fiber, they are a highly nutritious food rich in various vitamins and minerals. They also help alleviate inflammation and lower blood cholesterol.
북아프리카와 남서 아시아가 원산지이다. 두류 중 추위에 견디는 힘이 강한 반면 가뭄에는 매우 약한 작물로 꽃이 피면서부터는 고온다습한 조건이 필요해 주로 중국, 에티오피아, 이집트 등에서 생산되고 있다. 중국이 전 세계 총생산량의 약 70%를 점한다.Native to North Africa and southwestern Asia, it is a legume with strong cold tolerance but is highly susceptible to drought. It requires hot, humid conditions from the time it flowers, so it is primarily produced in China, Ethiopia, and Egypt. China accounts for approximately 70% of global production.
우리나라에는 1970년대 후반부터 제주도와 전남 남부 해안지역에서 재배되기 시작했으며, 1994년부터 남해와 사천지역에서 일본과의 계약재배를 계기로 점차 알려지고 있다.In Korea, it began to be cultivated in Jeju Island and the southern coastal region of Jeollanam-do in the late 1970s, and has gradually become known since 1994 through contract cultivation with Japan in the Namhae and Sacheon regions.
잠두는 단백질과 식이섬유가 풍부하게 함유되어 있으며, 지방은 적고 비타민 A, B1, B2, C 등과 각종 무기질을 고루 가진 영양가 높은 식품이다. 특히 비타민 B1과 티아민, 철, 구리, 인, 칼슘 및 마그네슘의 좋은 공급원이기도 하다. 잠두에 함유된 비타민 B1은 신경계 기능과 에너지 대사에 중요한 역할을 하고, 철분과 구리는 적혈구를 형성하는 데 도움을 주며 인과 마그네슘은 튼튼한 뼈를 유지하는 데 도움을 준다. 또한 잠두는 치질, 축농증, 중이염, 위염 등 염증 완화에 도움을 주고 혈중 콜레스테롤을 감소시키는 효능이 있다. 한방에서는 약용으로 이용되기도 하는데 잠두의 성숙 종자와 잎은 지열제, 이뇨제, 해독제 등으로 쓰인다.Broad beans are rich in protein and dietary fiber, low in fat, and are a highly nutritious food containing vitamins A, B1, B2, and C, as well as various minerals. They are also a good source of vitamin B1, thiamine, iron, copper, phosphorus, calcium, and magnesium. Vitamin B1, found in broad beans, plays a crucial role in nervous system function and energy metabolism. Iron and copper help form red blood cells, while phosphorus and magnesium help maintain strong bones. Broad beans also help alleviate inflammation, such as hemorrhoids, sinusitis, otitis media, and gastritis, and have the effect of lowering blood cholesterol. In oriental medicine, they are also used medicinally, with mature seeds and leaves used as a laxative, diuretic, and detoxifier.
본 발명은 위와 같은 배경하에서 안출된 것으로, 동물 조직이 아닌 식물로서 파바빈 유래의 PDRN을 제조하고 그에 따른 효능을 확인하여 화장품 조성물로서의 가능성을 실험적으로 입증하고자 한다.The present invention was conceived under the above background, and aims to experimentally prove the possibility of using PDRN as a cosmetic composition by producing PDRN derived from faba bean as a plant rather than an animal tissue and confirming its efficacy.
본 발명은 파바빈 유래 PDRN을 유효성분으로 포함하는 화장료 조성물인 것을 특징으로 한다.The present invention is characterized by being a cosmetic composition comprising PDRN derived from faba bean as an active ingredient.
이때 상기 화장료 조성물은 색소침착 방지, 미백, 주름개선, 피부탄력 개선, 항염 중 적어도 하나의 용도를 갖는 것임을 특징으로 한다.At this time, the cosmetic composition is characterized in that it has at least one use among anti-pigmentation, whitening, wrinkle improvement, skin elasticity improvement, and anti-inflammation.
또한 상기 화장료 조성물은 색소침착 방지, 미백, 주름개선, 피부탄력 개선, 항염의 복합적인 용도를 동시에 갖는 것임을 특징으로 한다.In addition, the above cosmetic composition is characterized by having the combined uses of anti-pigmentation, whitening, wrinkle improvement, skin elasticity improvement, and anti-inflammation.
본 발명에 따른 파바빈 유래 PDRN은 우수한 색소침착 방지, 미백, 주름개선, 피부탄력 개선, 항염의 효과를 가지므로 화장료 조성물로서 유용하게 사용될 수 있다.PDRN derived from faba bean according to the present invention has excellent effects of preventing pigmentation, whitening, improving wrinkles, improving skin elasticity, and anti-inflammation, and thus can be usefully used as a cosmetic composition.
이하 본 발명을 구체적인 실시예와 함께 상세히 설명한다. 다만 하기 실시예는 본 발명의 이해를 돕기 위한 것으로 본 발명의 범위가 이에 제한되는 것은 아니다.The present invention is described in detail below with specific examples. However, the following examples are intended to aid understanding of the present invention and are not intended to limit the scope of the present invention.
A. 시료의 제조A. Preparation of samples
1. DNA 시료 제조방법1. DNA sample preparation method
(1) 식물 조직 준비(1) Plant tissue preparation
동결된 식물 또는 건조 식물을 막자사발 및 믹서를 이용하여 곱게 분쇄한 후 CTAB Extraction solution과 증류수를 첨가하여 혼합한다. 혼합물을 65℃에서 2시간 동안 방치한다.Frozen or dried plants are finely ground using a mortar and pestle and a mixer, then CTAB Extraction Solution and distilled water are added and mixed. The mixture is left at 65°C for 2 hours.
(2) SDS 처리(2) SDS processing
20% SDS 용액을 혼합물의 10%를 첨가하고, 65℃에서 1시간 동안 반응시킨다.Add 10% of the mixture to a 20% SDS solution and react at 65°C for 1 hour.
(3) 칼륨아세트산처리(3) Potassium acetate treatment
반응된 혼합물에 5M 칼륨아세트산을 첨가하고 충분히 흔들어 섞은 후, -20℃에서 밤새 침전시킨다.Add 5M potassium acetate to the reacted mixture, shake well to mix, and precipitate overnight at -20°C.
(4) 원심분리(4) Centrifugation
혼합물을 4℃에서 3,000 rpm으로 30분간 원심 분리하여 상층액을 분리한다.Centrifuge the mixture at 3,000 rpm at 4°C for 30 minutes to separate the supernatant.
(5) DNA 침전(5) DNA precipitation
상층액을 새로운 튜브에 옮기고, 상층액 부피의 30%에 해당하는 isopropanol을 첨가한 후, -20℃에서 밤새 침전시킨다.Transfer the supernatant to a new tube, add isopropanol equivalent to 30% of the supernatant volume, and precipitate overnight at -20°C.
(6) 원심분리 및 에탄올 세척(6) Centrifugation and ethanol washing
침전물을 포함한 용액을 4℃에서 3,000 rpm으로 30분간 원심 분리하여 DNA를 침전시킨다.Centrifuge the solution containing the precipitate at 3,000 rpm at 4°C for 30 minutes to precipitate the DNA.
상층액을 제거한 뒤, 침전물에 70% ethanol을 첨가하고 3,000 rpm으로 30분간 원심 분리한 뒤 이 과정을 반복하여 침전물을 세척한다.After removing the supernatant, add 70% ethanol to the sediment, centrifuge at 3,000 rpm for 30 minutes, and repeat this process to wash the sediment.
(7) 에탄올 제거 및 건조(7) Ethanol removal and drying
상층액을 모두 제거한 후, 침전물을 3시간 동안 상온에서 건조하여 잔여 ethanol을 완전히 제거한다.After removing all supernatant, dry the sediment at room temperature for 3 hours to completely remove any residual ethanol.
(8) DNA 용해(8) DNA dissolution
건조된 DNA 침전물을 적절한 양의 증류수(DW)에 녹여 최종 용해된 DNA를 수득한다.The dried DNA precipitate is dissolved in an appropriate amount of distilled water (DW) to obtain the final dissolved DNA.
2. 추출물 시료 제조방법2. Extract sample preparation method
① DW 990g에 원물 10g을 혼합하였다.(추출 비율 10%)① 10g of raw material was mixed with 990g of DW (extraction ratio 10%).
② 추출 혼합액은 water bath에 넣고 일정 시간 55℃로 추출하였다.② The extraction mixture was placed in a water bath and extracted at 55℃ for a certain period of time.
③ 추출액은 필터한 후 멸균을 위해 autoclave 진행하였다.③ The extract was filtered and then autoclaved for sterilization.
④ 멸균한 시료는 Sample병에 넣어 준비한다.④ Prepare the sterilized sample by placing it in a sample bottle.
B. in vitro 실험B. In vitro experiments
1. DPPH 활성 저해능 실험1. DPPH activity inhibition experiment
(1) 실험목적(1) Purpose of the experiment
특정 물질의 DPPH radical 소거 활성능력을 평가하여 항산화 효과를 확인하고자 한다.The purpose of this study is to evaluate the DPPH radical scavenging activity of a specific substance to confirm its antioxidant effect.
(2) 실험군 및 대조군 준비(2) Preparation of experimental and control groups
실험군 : 단일 DNA sample 100ppm 용액Experimental group: 100 ppm solution of a single DNA sample
대조군 : 시료가 포함되지 않은 반응액Control: Reaction solution containing no sample
양성대조군(Positive Control): 500ppm의 Ascorbic acid 용액Positive Control: 500 ppm Ascorbic acid solution
(3) 실험과정(3) Experimental process
96-well plate를 사용하여 각 웰에 다음 순서대로 분주한다.Using a 96-well plate, dispense into each well in the following order.
① 일정 농도로 희석한 Sample을 준비한다.① Prepare a sample diluted to a certain concentration.
② 0.2mM로 희석한 DPPH를 준비한다(용매는 99% 메탄올을 사용한다).② Prepare DPPH diluted to 0.2 mM (use 99% methanol as the solvent).
③ 96-well plate를 준비한다.③ Prepare a 96-well plate.
④ 우선 Sample을 희석한 용매와 농도별로 희석한 Sample을 100㎕씩 4곳에 넣는다.④ First, add 100㎕ of the solvent in which the sample was diluted and the sample diluted by concentration to 4 locations.
⑤ 99% 메탄올을 ④에 4곳 중 1곳에 100㎕씩 넣는다.⑤ Add 100㎕ of 99% methanol to each of the four locations in ④.
⑥ 0.2mM로 희석한 DPPH를 ④에 3곳에 100㎕ 넣는다.⑥ Add 100㎕ of DPPH diluted to 0.2 mM to 3 locations in ④.
⑦ DPPH를 넣은 즉시 30분간 암소에 보관한다.⑦ Immediately after adding DPPH, store in a dark place for 30 minutes.
⑧ 30분 후 517nm에서 흡광도를 측정한다.⑧ Measure the absorbance at 517 nm after 30 minutes.
⑨ 다음의 식에 대입하여 계산한다.⑨ Calculate by substituting into the following equation.
Sample OD = Sample이 들어있는 반응액 흡광도Sample OD = absorbance of the reaction solution containing the sample
Sample X OD = Sample이 들어 있지 않은 반응액 흡광도Sample X OD = Absorbance of the reaction solution without sample
2. 아질산염 소거능 실험2. Nitrite scavenging ability test
(1) 실험 시약 및 조건(1) Experimental reagents and conditions
- 추출물: 실험에 사용되는 샘플 1 mL- Extract: 1 mL of sample used in the experiment
- NaNO₂ 용액: 1 mL- NaNO₂ solution: 1 mL
- HCl: 0.1 M 용액, pH 1.2 조정- HCl: 0.1 M solution, pH adjusted to 1.2
- 증류수 (DW): 총 용액 부피를 10 mL로 맞춤- Distilled water (DW): Adjust the total solution volume to 10 mL
- Griess 시약:- Griess reagent:
- 1% sulfanilicacid- 1% sulfanilic acid
- 1% naphthylamine (혼합 비율 1:1)- 1% naphthylamine (mixing ratio 1:1)
- 2% acetic acid- 2% acetic acid
(2) 실험 과정(2) Experimental process
① 혼합 및 반응① Mixing and reaction
추출물 1 mL에 NaNO₂ 용액 1 mL, 0.1 M HCl을 첨가하여 pH를 1.3로 조정한 후, 증류수를 가하여 최종 부피가 10 mL가 되도록 한다.Add 1 mL of NaNO₂ solution and 0.1 M HCl to 1 mL of the extract to adjust the pH to 1.3, then add distilled water to make the final volume 10 mL.
이 용액을 37℃에서 1시간 동안 반응시킨다.This solution is reacted at 37°C for 1 hour.
② Griess 시약 반응② Griess reagent reaction
반응액1 mL를 취하여 다음의 시약을 순서대로 첨가한다.Take 1 mL of the reaction solution and add the following reagents in order.
2% acetic acid 5 mL, Griess 시약 0.4 mL (1% sulfanilicacid와 1% naphthylamine 혼합물) 혼합 후, 실온에서 15분 동안 반응시킨다.After mixing 5 mL of 2% acetic acid and 0.4 mL of Griess reagent (a mixture of 1% sulfanilicacid and 1% naphthylamine), react at room temperature for 15 minutes.
③ 흡광도 측정③ Absorbance measurement
반응 완료 후, 520 nm 파장에서 흡광도를 측정한다.After the reaction is complete, the absorbance is measured at a wavelength of 520 nm.
④ 공시험④ Public exam
Griess 시약 대신 증류수 0.4 mL를 사용하여 동일한 조건에서 실험을 수행한다.The experiment was performed under the same conditions using 0.4 mL of distilled water instead of Griess reagent.
(3) 계산방법은 다음과 같다.(3) The calculation method is as follows.
(4) 실험 결과의 활용(4) Use of experimental results
본 측정 방법으로 계산된 질산염 소거 능력은 샘플의 항산화 성질을 평가함과 동시에, 아질산염과 관련된 산화적 스트레스가 염증 반응과 밀접하게 연결되어 있다는 점에서 간접적으로 항염효과를 평가할 수 있는 지표로 활용될 수 있다.The nitrate scavenging capacity calculated by this measurement method can be used as an indicator to evaluate the antioxidant properties of a sample and indirectly evaluate the anti-inflammatory effect, given that oxidative stress associated with nitrite is closely linked to inflammatory responses.
3. Tyrosinase 활성 저해능 실험3. Tyrosinase activity inhibition experiment
(1) 실험목적(1) Purpose of the experiment
특정 물질의 Tyrosinase 효소활성 저해능력을 평가하여 색소침착 방지 및 피부 미백 효과를 확인하고자 한다.The purpose of this study was to evaluate the ability of a specific substance to inhibit tyrosinase enzyme activity and to confirm its anti-pigmentation and skin whitening effects.
(2) 실험군 및 대조군 준비(2) Preparation of experimental and control groups
실험군 : 단일 DNA sample 100ppm 용액Experimental group: 100 ppm solution of a single DNA sample
대조군 : 시료가 포함되지 않은 반응액Control: Reaction solution containing no sample
양성대조군(Positive Control): 500ppm의 Ascorbic acid 용액Positive Control: 500 ppm Ascorbic acid solution
(3) 실험과정(3) Experimental process
96-well plate를 사용하여 각 웰에 다음을 혼합한다.Using a 96-well plate, mix the following into each well:
샘플당 가로로 4개의 well을 사용하며 sample well은 3개, Blank well은 1개 사용한다.Four wells are used horizontally per sample, with three sample wells and one blank well.
① 50 μL의 시험물질 또는 대조군① 50 μL of test substance or control
② 80 μL의 1X PBS용액② 80 μL of 1X PBS solution
③ 50 μL의 2mM L-DOPA③ 50 μL of 2 mM L-DOPA
④ 20 μL의 Tyrosinase 효소용액(1000U/mL). sample Blank well과 control Blank well에는 같은 양의 1X PBS용액.④ 20 μL of Tyrosinase enzyme solution (1000 U/mL). The same amount of 1X PBS solution is added to the sample blank well and control blank well.
그다음 10~15min 반응시킨 후, 490nm에서 흡광도를 측정하고 대조군과 비교하여 시험 물질의 효소활성 저해율을 계산한다.After reacting for 10 to 15 minutes, measure the absorbance at 490 nm and compare it with the control group to calculate the enzyme activity inhibition rate of the test substance.
(4) 결과계산(4) Result calculation
Tyrosinase 활성 저해율(%): 아래 공식으로 각 시료의 Tyrosinase 활성 저해율을 계산:Tyrosinase activity inhibition rate (%): Calculate the tyrosinase activity inhibition rate of each sample using the formula below:
4. Collagenase 활성 저해능 실험4. Collagenase activity inhibition experiment
(1) 실험목적(1) Purpose of the experiment
특정 물질의 Collagenase 효소 활성 저해능력을 평가하여 주름개선 효능 및 항노화 효과를 확인하고자 한다.The purpose of this study was to evaluate the ability of a specific substance to inhibit collagenase enzyme activity and to confirm its wrinkle improvement and anti-aging effects.
(2) 샘플 및 대조군 준비(2) Preparation of samples and controls
Sample: 측정하고자 하는 시료를 100 μL 준비Sample: Prepare 100 μL of the sample you want to measure.
(-) Control: 시료가 포함되지 않은 반응액(-) Control: Reaction solution without sample
(+) Control: Collagenase 활성 저해를 이미 입증한 양성 대조군 EGCG (Epigallocatechin gallate) 물질 사용(+) Control: Use of EGCG (Epigallocatechin gallate), a positive control substance that has already been proven to inhibit collagenase activity.
(3) 실험과정(3) Experimental process
① 실험 조성① Experimental composition
Sample (또는 Control): 100 μL Sample (or Control): 100 μL
Substrate Buffer: 250 μL Substrate Buffer: 250 μL
Collagenase: 150 μL Collagenase: 150 μL
총 반응 부피: 500 μL Total reaction volume: 500 μL
② 반응 과정은 다음과 같다.② The reaction process is as follows.
e-tube에 Sample 또는 Control과 기질 및 Collagenase를 조합. Combine sample or control with substrate and collagenase in an e-tube.
실온에서 20분, 또는 37℃에서 30분 동안 반응. Reaction for 20 minutes at room temperature or 30 minutes at 37°C.
6% Citric Acid 500 μL를 첨가하여 반응 정지. Stop the reaction by adding 500 μL of 6% Citric Acid.
Ethyl Acetate 1,500 μL를 첨가하여 10분 반응 후 결정화된 콜라겐 용해. Add 1,500 μL of ethyl acetate and dissolve the crystallized collagen after 10 minutes of reaction.
상등액을 취하여 320 nm에서 흡광도를 측정. Take the supernatant and measure the absorbance at 320 nm.
(4) 결과 계산(4) Calculating results
아래 계산식을 통해 시료의 Collagenase 저해 활성을 정량적으로 평가한다.The collagenase inhibitory activity of the sample is quantitatively evaluated using the formula below.
저해율(%) = (1-시료의 absorbance/대조구의 absorbance) x 100Inhibition rate (%) = (1-absorbance of sample/absorbance of control) x 100
5. Elastase 활성 저해능 실험5. Elastase activity inhibition experiment
(1) 실험목적(1) Purpose of the experiment
특정 물질의 Elastase 효소 활성 저해능력을 평가하여 피부탄력 및 주름개선 효과를 확인한다.The ability of a specific substance to inhibit elastase enzyme activity is evaluated to determine its effect on improving skin elasticity and wrinkles.
(2) 실험군 및 대조군 준비(2) Preparation of experimental and control groups
실험군 : 단일 DNA sample 100ppm 용액Experimental group: 100 ppm solution of a single DNA sample
대조군 : 시료가 포함되지 않은 반응액Control: Reaction solution containing no sample
양성대조군(Positive Control): 500ppm의 Ascorbic acid 용액Positive Control: 500 ppm Ascorbic acid solution
(3) 실험과정(3) Experimental process
96-well plate를 사용하여 각 웰에 다음을 혼합한다.Using a 96-well plate, mix the following into each well:
샘플당 가로로 4개의 well을 사용하며 sample well은 3개, Blank well은 1개 사용한다.Four wells are used horizontally per sample, with three sample wells and one blank well.
① 20 μL의 시험물질 또는 대조군① 20 μL of test substance or control
② 140μL의 0.2M Tris-HCl 용액② 140 μL of 0.2 M Tris-HCl solution
③ 20 μL의 1.0mM elastase substrate(N-Succinyl-Ala-Ala-Ala-p-nitroanilide)③ 20 μL of 1.0mM elastase substrate (N-Succinyl-Ala-Ala-Ala-p-nitroanilide)
①~③ 혼합물을 10min 반응시킨다.①~③ Let the mixture react for 10 minutes.
④ 20 μL의 Elastase 효소용액(1unit/mL). sample Blank well과 control Blankwell에는 같은 양의 0.2M Tris-HCl용액.④ 20 μL of Elastase enzyme solution (1 unit/mL). The same amount of 0.2 M Tris-HCl solution is added to the sample blank well and control blank well.
그다음 20min 반응시킨 후, 405nm에서 흡광도를 측정하고 대조군과 비교하여 시험물질의 효소활성 저해율을 계산한다.After reacting for 20 minutes, the absorbance is measured at 405 nm and the enzyme activity inhibition rate of the test substance is calculated by comparing it with the control group.
(4) 결과계산(4) Result calculation
Elastase 활성 저해율(%): 아래 공식으로 각 시료의 Tyrosinase 활성 저해율 계산:Elastase activity inhibition rate (%): Calculate the tyrosinase activity inhibition rate for each sample using the formula below:
C. 후보군 Screening C. Candidate Screening
1. 파바빈 PDRN 전기영동 시험결과1. Results of the electrophoresis test of fababin PDRN
파바빈 PDRN에 대한 Agaros Gel에서의 전기영동 시험결과 PDRN의 농도는 1697.4ng/㎕이었으며, 260A/280A의 흡광도 측정을 통한 순도 확인 결과 1.925로 높은 순도를 가지는 것을 확인하였다(1.8~2.1 범위에서 순도가 높다고 판단함).The concentration of PDRN in the electrophoresis test on Agarose Gel for fababin PDRN was 1697.4 ng/㎕, and the purity was confirmed to be high at 1.925 through absorbance measurement at 260A/280A (the purity was judged to be high in the range of 1.8 to 2.1).
2. Collagenase Inhibition Assay 이용한 1차 Screening (12종)2. Primary Screening Using Collagenase Inhibition Assay (12 Types)
여러 가지 원물로부터 추출한 PDRN에 대한 효능을 평가하여 우수한 화장품적 효능을 가진 Phyto-PDRN을 선별하기 위해 12종(감초, 곤드레, 노랑트타리버섯, 녹차, 닥나무, 맥문동, 병풀, 엉겅퀴, 엘더꽃, 청미래덩굴, 파바빈, 햄프씨드)의 식물로부터 추출한 PDRN에 대해 Collagenase 억제효능 평가를 진행하였다. 각 PDRN은 100ppm의 동일한 농도에서 비교하였으며, 12종에 대해 진행한 Collagenase Inhibition Assay 결과는 아래와 같았다.In order to select Phyto-PDRN with excellent cosmetic efficacy by evaluating the efficacy of PDRN extracted from various raw materials, collagenase inhibitory efficacy was evaluated for PDRN extracted from 12 plants (licorice, burdock, yellow ttari mushroom, green tea, paper mulberry, Ophiopogon japonicus, centella asiatica, burdock, elderflower, smilax vine, faba bean, and hemp seed). Each PDRN was compared at the same concentration of 100 ppm, and the results of the collagenase inhibition assay performed on the 12 plants were as follows.
Collagenase 저해율 평가 결과 30% 이상인 7종(감초, 녹차, 맥문동, 병풀, 엘더꽃, 청미래덩굴, 파바빈)을 추가 효능평가 대상으로 선정하였다.Seven species (licorice, green tea, Ophiopogon japonicus, Centella asiatica, elderflower, Siberian chrysanthemum, and faba bean) with a collagenase inhibition rate of 30% or higher were selected for additional efficacy evaluation.
3. 2차 Screening을 위한 in-vitro 효능평가 (7종)3. In-vitro efficacy evaluation for secondary screening (7 types)
1) DPPH Radical Scavenging Assay (7종) 1) DPPH Radical Scavenging Assay (7 types)
1차 선정된 7종 (감초, 녹차, 맥문동, 병풀, 엘더꽃, 청미래덩굴, 파바빈)에 대해 항산화 효능을 비교하기 위해 DPPH Radical 소거능 시험을 진행하였으며, 결과 감초 PDRN이 82.14%로 가장 우수한 효능을 나타냈고, 이어서 병풀, 64.26%, 맥문동이 51.64%로 매우 우수한 항산화 효능을 나타냈다.To compare the antioxidant efficacy of the 7 species selected in the first round (licorice, green tea, Ophiopogon japonicus, centella asiatica, elderflower, smilax vine, and faba bean), a DPPH radical scavenging activity test was conducted. As a result, licorice PDRN showed the best efficacy at 82.14%, followed by centella asiatica at 64.26% and Ophiopogon japonicus at 51.64%, showing excellent antioxidant efficacy.
2) Elastase Inhibition Assay (7종) 2) Elastase Inhibition Assay (7 types)
1차 선정된 7종 (감초, 녹차, 맥문동, 병풀, 엘더꽃, 청미래덩굴, 파바빈)에 대해 피부탄력 개선 효능을 비교하기 위해 Elastase Inhibition Assay를 진행하였으며, 결과 맥문동 PDRN이 50.36%로 가장 우수한 효능을 나타냈고, 이어서 청미래덩굴, 42.32%, 엘더꽃이 30.79%로 우수한 Elastase 저해 효능을 나타냈다.To compare the skin elasticity improvement efficacy of the 7 species selected in the first round (licorice, green tea, Ophiopogon japonicus, centella asiatica, elderflower, schisandra chinensis, and faba bean), an Elastase Inhibition Assay was conducted. As a result, Ophiopogon japonicus PDRN showed the best efficacy at 50.36%, followed by schisandra chinensis at 42.32% and elderflower at 30.79%, showing excellent Elastase inhibition efficacy.
3) Tyrosinase Inhibition Assay (7종) 3) Tyrosinase Inhibition Assay (7 types)
1차 선정된 7종 (감초, 녹차, 맥문동, 병풀, 엘더꽃, 청미래덩굴, 파바빈)에 대해 피부미백 및 색소침착 개선 효능을 비교하기 위해 Tyrosinase Inhibition Assay를 진행하였으며, 결과 감초 PDRN이 45.24%로 가장 우수한 효능을 나타냈고, 파바빈 PDRN이 31.039%로 효과를 나타내었으나 나머지 PDRN은 Tyrosinase의 저해 효능은 우수하게 나타나지 않았다.In order to compare the skin whitening and pigmentation improvement efficacy of the 7 species selected in the first round (licorice, green tea, Ophiopogon japonicus, centella asiatica, elderflower, schisandra chinensis, and faba bean), a Tyrosinase Inhibition Assay was performed. As a result, licorice PDRN showed the best efficacy at 45.24%, followed by faba bean PDRN at 31.039%, but the remaining PDRN did not show excellent tyrosinase inhibition efficacy.
4) NO Assay (7종)4) NO Assay (7 types)
1차 선정된 7종 (감초, 녹차, 맥문동, 병풀, 엘더꽃, 청미래덩굴, 파바빈)에 대해 항염 효능을 알아보기 위해 아질산염 소거능 시험을 진행하였으며, 결과 병풀과 엘더꽃 PDRN에서 각각 66.65%와 60.29%의 우수한 항염 효능을 확인하였으며, 이어서 청미래덩굴과 감초가 54.27%와 52.58%의 우수한 항염 효능을 나타내는 것으로 확인되었다.To determine the anti-inflammatory efficacy of the 7 species selected in the first round (licorice, green tea, Ophiopogon japonicus, centella asiatica, elderflower, Smilax chinensis, and faba bean), a nitrite scavenging activity test was conducted. As a result, centella asiatica and elderflower PDRN were confirmed to have excellent anti-inflammatory efficacy of 66.65% and 60.29%, respectively, followed by Smilax chinensis and licorice to show excellent anti-inflammatory efficacy of 54.27% and 52.58%.
파바빈은 1차 선별된 7종 가운데에서 항산화를 제외한 전반적인 평가 항목에서 비교적 우수한 효능이 나타났기에 화장품 소재로서의 가치가 높다고 판단하여, 하기에서는 동일 식물의 일반 추출물과의 비교 평가를 통해 그 가능성을 확인하고자 하였다.Among the seven initially selected species, faba bean showed relatively excellent efficacy in all evaluation items except antioxidant activity, so it was judged to have high value as a cosmetic material. Therefore, the following was conducted to confirm its potential through comparative evaluation with general extracts of the same plant.
D. 추출물과의 비교 평가D. Comparative evaluation with extracts
파바빈의 일반 추출물과 PDRN의 효능을 비교 평가하였다. PDRN의 농도는 100ppm에서 평가를 진행하였다. 이를테면 1,000ppm 이상 고함량으로 처리시 수율과 순도를 높이기 위해 제조 공정과 제조비용이 증가하게 되며, 반대로 함량이 너무 낮게 되면 화장품에 사용시 유의미한 효능을 기대하기 어렵다고 판단되어, 제조비용과 유효농도를 고려하여 100ppm으로 실험을 진행하였다.The efficacy of a general extract of fava bean and PDRN was compared and evaluated. The PDRN concentration was evaluated at 100 ppm. For example, if the concentration is higher than 1,000 ppm, the manufacturing process and manufacturing costs increase to increase yield and purity. Conversely, if the concentration is too low, it is difficult to expect significant efficacy when used in cosmetics. Therefore, considering manufacturing costs and effective concentration, the experiment was conducted at 100 ppm.
100ppm은 %로 환산시 0.01%에 해당한다. 이는 아래 실험결과에서 일반 추출물의 함량 대비 매우 소량으로 비교한 결과이며, 이로써 후술하는 바와 같이 매우 적은 양으로도 상대적으로 우수하거나 유사한 효능을 나타내기 때문에 기술적으로 가치가 있다고 판단된다.100 ppm is equivalent to 0.01% when converted to a percentage. This is the result of comparing a very small amount compared to the content of a general extract in the experimental results below. As such, it is judged to have technological value because it exhibits relatively superior or similar efficacy even in very small amounts, as described below.
1. Nitrite scavenging activity1. Nitrite scavenging activity
Nitrite scavenging activity는 항염 효능을 평가하기 위해 가장 일반적이고 널리 사용되는 평가법이다. 0.1%, 1%, 3% 파바빈 추출물과 100ppm 파바빈 PDRN를 대상으로 Nitrite scavenging activity를 실시한 결과 일반 추출물에서는 아질산염 소거능이 각각 4.43%, 24.41%, 35.86%인데 반해 파바빈 PDRN에서는 약 40%의 소거효능을 나타내 추출물에 비해 시험 농도 범위 내에서 최소 9.98% ~ 790.29%까지 소거 효능이 더 우수함을 확인하였다. 이를 통해 파바빈 DNA가 우수한 항염효능을 가지고 있어, 피부 진정 효능이나 피부트러블로부터 피부를 보호하는 효능을 가짐을 확인하였다.Nitrite scavenging activity is the most common and widely used evaluation method to evaluate anti-inflammatory efficacy. Nitrite scavenging activity was tested on 0.1%, 1%, and 3% faba bean extracts and 100 ppm faba bean PDRN. As a result, while the nitrite scavenging activity of the general extract was 4.43%, 24.41%, and 35.86%, respectively, faba bean PDRN showed approximately 40% scavenging efficacy, confirming that the scavenging efficacy was superior to the extract by at least 9.98% to 790.29% within the test concentration range. This confirmed that faba bean DNA has excellent anti-inflammatory efficacy, and has skin soothing effects and effects to protect the skin from skin troubles.
2. Tyrosinase Inhibition Assay2. Tyrosinase Inhibition Assay
파바빈 추출물과 파바빈 DNA를 대상으로 Tyrosinase Inhibition Assay를 수행하였다. 추출물의 경우 Tyrosinase 억제율이 0.1%, 1%, 3% 농도에서 각각 4.51%, 23.57%, 27.6%의 억제능을 보여 1% 이상의 농도에서 유의미한 결과를 보였으며, 100ppm의 파바빈 PDRN에서는 31.03%의 억제 효능을 보여 일반 추출물 대비 우수한 효능을 확인하였다. 추출물의 시험 범위 내에서 농도에 따라 다르지만 12.43% ~ 588.03%까지 PDRN이 더 우수한 억제 효능을 나타내며, 이를 근거로 파바빈 DNA는 색소침착을 방지하거나 멜라닌 합성을 억제해 미백효능을 부여하는 화장품 소재로서 사용이 가능함을 확인하였다.Tyrosinase Inhibition Assay was performed on faba bean extract and faba bean DNA. In the case of the extract, the tyrosinase inhibition rate showed 4.51%, 23.57%, and 27.6% inhibition ability at concentrations of 0.1%, 1%, and 3%, respectively, and showed significant results at concentrations above 1%. Faba bean PDRN at 100 ppm showed an inhibition efficacy of 31.03%, confirming superior efficacy compared to the general extract. Within the test range of the extract, PDRN showed a superior inhibition efficacy ranging from 12.43% to 588.03% depending on the concentration, and based on this, it was confirmed that faba bean DNA can be used as a cosmetic material that prevents pigmentation or inhibits melanin synthesis to impart whitening effects.
3. Collagenase Inhibition Assay3. Collagenase Inhibition Assay
Collagen은 피부에서 가장 중요한 성분으로 피부의 구조를 유지하고 보습, 탄력 등을 유지하는 데 가장 중요한 역할을 하는 성분이다. Collagen이 부족하면 피부의 보습력 유지가 어려워지고, 피부탄력이 감소하여 주름이 발생하게 된다. 때문에 Collagen은 피부노화 방지 및 주름개선 분야에서 가장 중요한 피부 구성성분이다. Collagenase는 Collagen을 분해하는 효소로 주름개선 및 항노화 연구 분야에서 가장 중요한 타겟성분이다. 파바빈을 소재로 추출물과 DNA의 Collagenase 억제효능을 비교하였을 때, 추출물 농도 0.1%, 1%, 3%에서 각각 6.97%, 20.57%, 24.58%의 Collagenase 억제 효능을 보여 1% 이상의 추출물에서 유의미한 효능이 있음을 확인하였지만, 파바빈 PDRN의 경우 100ppm의 농도에서 35.03%의 억제 효능을 나타내 추출물 대비 시험 농도 범위에서 적게는 42.51%부터 402.58% 정도까지 효능이 더 우수함을 확인하였다. 이는 파바빈을 그냥 추출해서 사용하는 것보다 DNA를 추출해서 사용하는 것이 주름 개선이나 주름 예방용 제품 개발을 위해서 더 좋은 선택이 될 수 있음을 보여준다.Collagen is the most important component of skin, playing a crucial role in maintaining its structure, hydration, and elasticity. A collagen deficiency makes it difficult for skin to maintain moisture, reduces elasticity, and leads to wrinkles. Therefore, collagen is the most crucial component in anti-aging and wrinkle improvement. Collagenase, an enzyme that breaks down collagen, is a key target ingredient in wrinkle improvement and anti-aging research. When comparing the collagenase inhibitory efficacy of the extract and DNA using faba bean as the material, the collagenase inhibitory efficacy was 6.97%, 20.57%, and 24.58% at extract concentrations of 0.1%, 1%, and 3%, respectively, confirming that significant efficacy was present in extracts of 1% or more. However, in the case of faba bean PDRN, the inhibitory efficacy was 35.03% at a concentration of 100 ppm, confirming that the efficacy was superior to the extract, ranging from 42.51% to 402.58% over the tested concentration range. This shows that using DNA extracted from faba bean rather than extracting it as is can be a better choice for developing products for wrinkle improvement or wrinkle prevention.
4 Elastase Inhibition Assay4 Elastase Inhibition Assay
Elastin은 피부의 탄력에 관여하는 단백질이며, Elastase는 Elastin을 분해하는 효소이다. Elastin이 분해되면 피부의 탄력이 떨어지고 주름 발생의 원인이 된다. 파바빈추출물은 단백질이 풍부할 것으로 예상되며 이로 인해 Elastase의 발현억제 효능이 있을 것으로 예상된다. 시험 결과 0.1%, 1%, 3%의 추출물에서 각각 7.51%, 23.53%, 25.36% Elastase 억제효능이 확인되었으며, 이에 반해 100ppm 파바빈 PDRN에서는 31.11%의 Elastase 억제효능이 확인되어 추출물 대비 22.67% ~314.25% 억제효능이 우수함을 확인하였다. 이는 파바빈 DNA가 탄력이나 주름을 개선하는 화장료로서의 가능성을 보여준다.Elastin is a protein involved in skin elasticity, and elastase is an enzyme that breaks down elastin. When elastin breaks down, skin elasticity decreases and wrinkles form. Fava bean extract is expected to be rich in protein, which is expected to have an elastase expression inhibition effect. The test results confirmed that 0.1%, 1%, and 3% extracts had an elastase inhibition effect of 7.51%, 23.53%, and 25.36%, respectively. In contrast, 100 ppm fava bean PDRN confirmed an elastase inhibition effect of 31.11%, confirming an inhibition effect of 22.67% to 314.25% superior to the extract. This shows that fava bean DNA has the potential to be a cosmetic that improves elasticity and wrinkles.
Claims (3)
상기 화장료 조성물의 용도는 색소침착 방지, 미백, 주름개선, 피부탄력 개선, 항염 중 적어도 하나인 것을 특징으로 하는 화장료 조성물.In the first paragraph,
A cosmetic composition characterized in that the use of the cosmetic composition is at least one of anti-pigmentation, whitening, wrinkle improvement, skin elasticity improvement, and anti-inflammation.
상기 화장료 조성물의 용도는 색소침착 방지, 미백, 주름개선, 피부탄력 개선, 항염의 복합 용도인 것을 특징으로 하는 화장료 조성물.In the second paragraph,
The cosmetic composition is characterized in that the above cosmetic composition has a combined use of preventing pigmentation, whitening, improving wrinkles, improving skin elasticity, and anti-inflammation.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020240185743 | 2024-12-13 | ||
| KR20240185743 | 2024-12-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR102843808B1 true KR102843808B1 (en) | 2025-08-12 |
Family
ID=96733716
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020250066915A Active KR102843808B1 (en) | 2024-12-13 | 2025-05-22 | The cosmetic composition containing Vicia faba-derived PDRN |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR102843808B1 (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102237543B1 (en) | 2019-02-22 | 2021-04-07 | (주)모아캠 | Method of Producing DNA Derived from Aloe Genus Plant, and Composition Containing DNA Derived from Aloe Genus Plant for Anti-Aging and Anti-Inflammation |
| KR102682938B1 (en) * | 2023-08-11 | 2024-07-09 | 주식회사 바이오에프디엔씨 | Method for producing PDRN from plant body |
| KR102707680B1 (en) | 2024-02-02 | 2024-09-19 | 주식회사 에이바이오머티리얼즈 | Preparation method of high-purity plant-derived PDRN with excellent storage stability and composition for anti-inflammation, skin regeneration and wound healing containing the same |
-
2025
- 2025-05-22 KR KR1020250066915A patent/KR102843808B1/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102237543B1 (en) | 2019-02-22 | 2021-04-07 | (주)모아캠 | Method of Producing DNA Derived from Aloe Genus Plant, and Composition Containing DNA Derived from Aloe Genus Plant for Anti-Aging and Anti-Inflammation |
| KR102682938B1 (en) * | 2023-08-11 | 2024-07-09 | 주식회사 바이오에프디엔씨 | Method for producing PDRN from plant body |
| KR102707680B1 (en) | 2024-02-02 | 2024-09-19 | 주식회사 에이바이오머티리얼즈 | Preparation method of high-purity plant-derived PDRN with excellent storage stability and composition for anti-inflammation, skin regeneration and wound healing containing the same |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101897488B1 (en) | Cosmetic composition for Strengthening skin barrier, skin regeneration and skin moisturization | |
| KR101566320B1 (en) | Cosmetic composition comprising an Impatiens balsamina L, Maca, Rosa multiflora Thunberg, Eryobotrya japonica and Pachyrrhizus erosus Complex-fermented extract | |
| JP7708495B2 (en) | Anti-aging agents, antioxidants, anti-inflammatory agents, skin whitening agents, and cosmetics | |
| KR20090081178A (en) | Cosmetic composition containing wildflower extract | |
| KR101312965B1 (en) | The cosmetic composition for anti-wrinkle comprising the mixture of extract of Allium cepa, Symphytum officinale, Eclipta prostrate, and Theobroma cacao | |
| KR101333676B1 (en) | Cosmetic composition for reducing skin pore size and secreting sebum containing the extract of oenothera odorata jacq., pueraria radix, pine tree leaves and ulmus pumila l | |
| KR100443588B1 (en) | Cosmetic composition containing paeonia suffruticosa andrews extract and albizzia julibrissin dura extract having anti-ageing effect | |
| JP2011168555A (en) | Differentiation method | |
| JP2011168555A5 (en) | ||
| KR101930264B1 (en) | Cosmetic composition for inhibiting secretion of sebum and for improving acne symptoms containing natural complex extract | |
| KR20190076620A (en) | Cosmetic composition having anti-depigmenting and whitening function and manufacturing method thereof | |
| Abay et al. | Investigation of antioxidant activities of fruit, leaf, and branche extracts of white (Morus alba L.) and black (Morus nigra L.) mulberry species from diyarbakır | |
| KR102453269B1 (en) | Cosmetic composition containing starfish extract and hydrolyzed collagen as active ingredients to improve skin wrinkles, promote collagen synthesis, and moisturize | |
| KR102817536B1 (en) | Natural licorice extract with anti-inflammatory effect, centella asiatica extract and plant-based squalane complex cosmetic composition with moisturizing effect | |
| KR100820237B1 (en) | Cosmetic composition comprising a complex herbal extract showing antioxidant and moisturizing activity | |
| KR102843808B1 (en) | The cosmetic composition containing Vicia faba-derived PDRN | |
| KR101126984B1 (en) | Cosmetic composition comprising extract of taxodium distichum and viburnum sargentii for sterile for whitening and antioxdiant | |
| KR20150089234A (en) | Cosmetic composition comprising Reynoutria sachalinensis extracts for skin anti-wrinkle effect | |
| KR102843806B1 (en) | The cosmetic composition containing elderberry-derived PDRN | |
| KR102843810B1 (en) | The cosmetic composition containing Glycyrrhiza uralensis-derived PDRN | |
| KR100770140B1 (en) | Wipes composition containing a mixed extract of birch sap and rhubarb | |
| KR102843852B1 (en) | The cosmetic composition containing Centella asiatica and Sambucus nigra derived PDRN | |
| CN115770209A (en) | Rod-shaped lithospermum ointment containing three-purple oil and preparation method thereof | |
| KR102843816B1 (en) | The cosmetic composition containing Centella asiatica and Camellia sinensis derived PDRN | |
| KR102076746B1 (en) | Mixed cosmetic composition comprising flower |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
St.27 status event code: A-0-1-A10-A12-nap-PA0109 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| PA0302 | Request for accelerated examination |
St.27 status event code: A-1-2-D10-D16-exm-PA0302 |
|
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
| F11 | Ip right granted following substantive examination |
Free format text: ST27 STATUS EVENT CODE: A-2-4-F10-F11-EXM-PR0701 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U11-oth-PR1002 Fee payment year number: 1 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-OTH-PR1002 (AS PROVIDED BY THE NATIONAL OFFICE) Year of fee payment: 1 |
|
| PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |
|
| Q13 | Ip right document published |
Free format text: ST27 STATUS EVENT CODE: A-4-4-Q10-Q13-NAP-PG1601 (AS PROVIDED BY THE NATIONAL OFFICE) |